Cost-Effectiveness of Sotagliflozin in Heart Failure Patients with Preserved and Reduced Ejection Fractions – Results from SOLOIST-WHF. // The American Journal of Cardiology. – URL: https://www.sciencedirect.com/science/article/pii/S0002914926006016?dgcid=rss_sd_all
Cost-Effectiveness of Sotagliflozin in Heart Failure Patients with Preserved and Reduced Ejection Fractions – Results from SOLOIST-WHF. The American Journal of Cardiology. https://www.sciencedirect.com/science/article/pii/S0002914926006016?dgcid=rss_sd_all
“Cost-Effectiveness of Sotagliflozin in Heart Failure Patients with Preserved and Reduced Ejection Fractions – Results from SOLOIST-WHF.” The American Journal of Cardiology.
@article{article95282,
title = {Cost-Effectiveness of Sotagliflozin in Heart Failure Patients with Preserved and Reduced Ejection Fractions – Results from SOLOIST-WHF},
journal = {The American Journal of Cardiology},
url = {https://www.sciencedirect.com/science/article/pii/S0002914926006016?dgcid=rss_sd_all}
}